De-Escalating Bone-Modifying Agents in Cancer With Bone Mets De-Escalating Bone-Modifying Agents in Cancer With Bone Mets

There may be many benefits to increasing the dosing interval of bone-modifying agents in patients with bone metastases, but important questions remain such as when to start and stop these agents.Journal of Oncology Practice
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news